CNY 35.85
(0.87%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 7.89 Billion CNY | 11.11% |
2022 | 7.1 Billion CNY | 3.01% |
2021 | 6.89 Billion CNY | 2.51% |
2020 | 6.72 Billion CNY | 45.08% |
2019 | 4.63 Billion CNY | 10.82% |
2018 | 4.18 Billion CNY | 18.12% |
2017 | 3.54 Billion CNY | 34.53% |
2016 | 2.63 Billion CNY | 25.14% |
2015 | 2.1 Billion CNY | 25.09% |
2014 | 1.68 Billion CNY | 18.08% |
2013 | 1.42 Billion CNY | 8.54% |
2012 | 1.31 Billion CNY | 12.11% |
2011 | 1.17 Billion CNY | 32.43% |
2010 | 883.9 Million CNY | 64.33% |
2009 | 537.88 Million CNY | 34.01% |
2008 | 401.37 Million CNY | 38.65% |
2007 | 289.48 Million CNY | 24.78% |
2006 | 231.99 Million CNY | 9.16% |
2005 | 212.53 Million CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 2.05 Billion CNY | -6.83% |
2024 Q1 | 2.2 Billion CNY | 70.53% |
2024 Q3 | 1.7 Billion CNY | -17.26% |
2023 Q4 | 1.29 Billion CNY | -23.04% |
2023 Q2 | 2.27 Billion CNY | -15.73% |
2023 FY | 7.89 Billion CNY | 11.11% |
2023 Q1 | 2.7 Billion CNY | 36.12% |
2023 Q3 | 1.68 Billion CNY | -26.09% |
2022 Q1 | 1.82 Billion CNY | 14.96% |
2022 Q4 | 1.98 Billion CNY | 26.99% |
2022 FY | 7.1 Billion CNY | 3.01% |
2022 Q3 | 1.56 Billion CNY | -9.72% |
2022 Q2 | 1.73 Billion CNY | -4.91% |
2021 Q1 | 1.66 Billion CNY | -11.5% |
2021 FY | 6.89 Billion CNY | 2.51% |
2021 Q2 | 1.93 Billion CNY | 16.23% |
2021 Q3 | 1.71 Billion CNY | -11.06% |
2021 Q4 | 1.58 Billion CNY | -7.77% |
2020 Q3 | 1.42 Billion CNY | -29.67% |
2020 Q4 | 1.87 Billion CNY | 31.52% |
2020 FY | 6.72 Billion CNY | 45.08% |
2020 Q2 | 2.02 Billion CNY | 45.92% |
2020 Q1 | 1.39 Billion CNY | 28.84% |
2019 FY | 4.63 Billion CNY | 10.82% |
2019 Q1 | 1.2 Billion CNY | 19.76% |
2019 Q2 | 1.3 Billion CNY | 8.26% |
2019 Q4 | 1.07 Billion CNY | 2.36% |
2019 Q3 | 1.05 Billion CNY | -18.9% |
2018 Q1 | 1.04 Billion CNY | 22.67% |
2018 Q3 | 957.27 Million CNY | -18.99% |
2018 Q4 | 1 Billion CNY | 4.77% |
2018 Q2 | 1.18 Billion CNY | 13.45% |
2018 FY | 4.18 Billion CNY | 18.12% |
2017 Q3 | 831.18 Million CNY | -13.37% |
2017 FY | 3.54 Billion CNY | 34.53% |
2017 Q1 | 901.86 Million CNY | 42.45% |
2017 Q2 | 959.45 Million CNY | 6.39% |
2017 Q4 | 849.05 Million CNY | 2.15% |
2016 Q1 | 726.93 Million CNY | 54.59% |
2016 FY | 2.63 Billion CNY | 25.14% |
2016 Q2 | 701.53 Million CNY | -3.49% |
2016 Q4 | 633.1 Million CNY | 10.87% |
2016 Q3 | 571.01 Million CNY | -18.6% |
2015 Q3 | 541.75 Million CNY | -2.57% |
2015 Q4 | 470.24 Million CNY | -13.2% |
2015 FY | 2.1 Billion CNY | 25.09% |
2015 Q1 | 535.67 Million CNY | 68.96% |
2015 Q2 | 556.06 Million CNY | 3.81% |
2014 Q2 | 472.21 Million CNY | 1.85% |
2014 Q1 | 463.64 Million CNY | 58.22% |
2014 Q4 | 317.04 Million CNY | -26.08% |
2014 FY | 1.68 Billion CNY | 18.08% |
2014 Q3 | 428.9 Million CNY | -9.17% |
2013 Q3 | 384.74 Million CNY | 0.05% |
2013 Q4 | 293.04 Million CNY | -23.83% |
2013 FY | 1.42 Billion CNY | 8.54% |
2013 Q1 | 361.98 Million CNY | 17.35% |
2013 Q2 | 384.54 Million CNY | 6.23% |
2012 FY | 1.31 Billion CNY | 12.11% |
2012 Q4 | 308.47 Million CNY | -5.92% |
2012 Q1 | 325.95 Million CNY | 14.16% |
2012 Q3 | 327.88 Million CNY | -6.29% |
2012 Q2 | 349.89 Million CNY | 7.34% |
2011 Q4 | 285.51 Million CNY | 3.57% |
2011 FY | 1.17 Billion CNY | 32.43% |
2011 Q3 | 275.65 Million CNY | -7.85% |
2011 Q2 | 299.14 Million CNY | -3.56% |
2011 Q1 | 310.2 Million CNY | 35.75% |
2010 Q3 | 220.66 Million CNY | -3.39% |
2010 Q4 | 228.51 Million CNY | 3.56% |
2010 Q2 | 228.41 Million CNY | 10.72% |
2010 Q1 | 206.3 Million CNY | 61.08% |
2010 FY | 883.9 Million CNY | 64.33% |
2009 Q3 | 139.06 Million CNY | -5.68% |
2009 Q4 | 128.07 Million CNY | -7.9% |
2009 Q1 | 123.3 Million CNY | 28.29% |
2009 FY | 537.88 Million CNY | 34.01% |
2009 Q2 | 147.43 Million CNY | 19.57% |
2008 Q2 | 111.55 Million CNY | 28.1% |
2008 Q4 | 96.12 Million CNY | -9.84% |
2008 Q3 | 106.61 Million CNY | -4.43% |
2008 FY | 401.37 Million CNY | 38.65% |
2008 Q1 | 87.08 Million CNY | 12.66% |
2007 Q2 | 70.58 Million CNY | 11.07% |
2007 Q4 | 77.3 Million CNY | -0.95% |
2007 FY | 289.48 Million CNY | 24.78% |
2007 Q1 | 63.55 Million CNY | 0.0% |
2007 Q3 | 78.04 Million CNY | 10.56% |
2006 FY | 231.99 Million CNY | 9.16% |
2005 FY | 212.53 Million CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Shenzhen Salubris Pharmaceuticals Co., Ltd. | 3.36 Billion CNY | -134.461% |
Blue Sail Medical Co.,Ltd. | 4.92 Billion CNY | -60.144% |
Andon Health Co., Ltd. | 3.18 Billion CNY | -147.63% |
Allmed Medical Products Co., Ltd | 2.75 Billion CNY | -186.231% |
Improve Medical Instruments Co., Ltd. | 644.62 Million CNY | -1124.041% |
Tofflon Science and Technology Group Co., Ltd. | 5.64 Billion CNY | -39.859% |
Truking Technology Limited | 6.8 Billion CNY | -15.964% |
Jiangxi Sanxin Medtec Co.,Ltd. | 1.3 Billion CNY | -506.927% |
Shenyang Xingqi Pharmaceutical Co.,Ltd | 1.46 Billion CNY | -437.652% |
Autek China Inc. | 1.73 Billion CNY | -354.212% |
Intco Medical Technology Co., Ltd. | 6.91 Billion CNY | -14.045% |
Jiangsu Apon Medical Technology Co., Ltd. | 417.98 Million CNY | -1787.746% |
Winner Medical Co., Ltd. | 8.18 Billion CNY | 3.599% |
Imeik Technology Development Co.,Ltd. | 2.85 Billion CNY | -176.471% |
Zhonghong Pulin Medical Products Co., Ltd. | 2.1 Billion CNY | -274.798% |
Caina Technology Co., Ltd. | 410.47 Million CNY | -1822.287% |